Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Selleslag

Showing results (21-30 of 44) with videos related to

Pageof 5
Sort By:
Leukemia|November 1, 1995
Intensive chemotherapy for poor prognosis myelodysplasia (MDS) and secondary acute myeloid leukemia (sAML) following MDS of more than 6 months duration. A pilot study by the Leukemia Cooperative Group of the European Organisation for Research and Treatment in Cancer (EORTC-LCG)T de Witte, S Suciu, M Peetermans, et al.
Acta Clinica Belgica|September 20, 2014
Plerixafor prescription modalities in autologous haematopoietic stem cell mobilization in BelgiumD Selleslag, C Lambert, P Zachee, et al.
Blood|March 7, 1998
Fluorescence in situ hybridization characterization of new translocations involving TEL (ETV6) in a wide spectrum of hematologic malignanciesI Wlodarska, R La Starza, M Baens, et al.
The Journal of Antimicrobial Chemotherapy|June 22, 2001
Itraconazole versus amphotericin B plus nystatin in the prophylaxis of fungal infections in neutropenic cancer patientsM Boogaerts, J Maertens, A van Hoof, et al.
Annals of Hematology|March 1, 1996
Salvage treatment for primary resistant acute myelogenous leukemia consisting of intermediate-dose cytosine arabinoside and interspaced continuous infusions of idarubicin: a phase-II study (no. 06901) of the EORTC Leukemia Cooperative GroupT De Witte, S Suciu, D Selleslag, et al.
Acta Clinica Belgica|December 3, 2014
Safety and efficacy of azacitidine in Belgian patients with high-risk myelodysplastic syndromes, acute myeloid leukaemia, or chronic myelomonocytic leukaemia: results of a real-life, non-interventional post-marketing surveyY Beguin, D Selleslag, S Meers, et al.
Leukemia|August 2, 2001
A novel recurrent translocation t(11;14)(p11;q32) in splenic marginal zone B cell lymphomaA Cuneo, A Bardi, I Wlodarska, et al.
Genes, Chromosomes & Cancer|May 23, 1998
FISH identifies inv(16)(p13q22) masked by translocations in three cases of acute myeloid leukemiaJ Dierlamm, M Stul, H Vranckx, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 31, 2014
Preference for involvement in treatment decisions and request for prognostic information in newly diagnosed patients with higher-risk myelodysplastic syndromesF Efficace, G Gaidano, M Sprangers, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 30, 1998
An EORTC international multicenter randomized trial (EORTC number 19923) comparing two dosages of liposomal amphotericin B for treatment of invasive aspergillosisM Ellis, D Spence, B de Pauw, et al.
Pageof 5

Showing results (21-30 of 44) with videos related to

Sort By:
Pageof 5
Leukemia|November 1, 1995
Intensive chemotherapy for poor prognosis myelodysplasia (MDS) and secondary acute myeloid leukemia (sAML) following MDS of more than 6 months duration. A pilot study by the Leukemia Cooperative Group of the European Organisation for Research and Treatment in Cancer (EORTC-LCG)T de Witte, S Suciu, M Peetermans, et al.
Acta Clinica Belgica|September 20, 2014
Plerixafor prescription modalities in autologous haematopoietic stem cell mobilization in BelgiumD Selleslag, C Lambert, P Zachee, et al.
Blood|March 7, 1998
Fluorescence in situ hybridization characterization of new translocations involving TEL (ETV6) in a wide spectrum of hematologic malignanciesI Wlodarska, R La Starza, M Baens, et al.
The Journal of Antimicrobial Chemotherapy|June 22, 2001
Itraconazole versus amphotericin B plus nystatin in the prophylaxis of fungal infections in neutropenic cancer patientsM Boogaerts, J Maertens, A van Hoof, et al.
Annals of Hematology|March 1, 1996
Salvage treatment for primary resistant acute myelogenous leukemia consisting of intermediate-dose cytosine arabinoside and interspaced continuous infusions of idarubicin: a phase-II study (no. 06901) of the EORTC Leukemia Cooperative GroupT De Witte, S Suciu, D Selleslag, et al.
Acta Clinica Belgica|December 3, 2014
Safety and efficacy of azacitidine in Belgian patients with high-risk myelodysplastic syndromes, acute myeloid leukaemia, or chronic myelomonocytic leukaemia: results of a real-life, non-interventional post-marketing surveyY Beguin, D Selleslag, S Meers, et al.
Leukemia|August 2, 2001
A novel recurrent translocation t(11;14)(p11;q32) in splenic marginal zone B cell lymphomaA Cuneo, A Bardi, I Wlodarska, et al.
Genes, Chromosomes & Cancer|May 23, 1998
FISH identifies inv(16)(p13q22) masked by translocations in three cases of acute myeloid leukemiaJ Dierlamm, M Stul, H Vranckx, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 31, 2014
Preference for involvement in treatment decisions and request for prognostic information in newly diagnosed patients with higher-risk myelodysplastic syndromesF Efficace, G Gaidano, M Sprangers, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 30, 1998
An EORTC international multicenter randomized trial (EORTC number 19923) comparing two dosages of liposomal amphotericin B for treatment of invasive aspergillosisM Ellis, D Spence, B de Pauw, et al.
Pageof 5